Arthritis drug may mask diabetes, study warns
NCT ID NCT07416656
First seen Feb 24, 2026 · Last updated May 14, 2026 · Updated 11 times
Summary
This study looks at whether the arthritis drug sulfasalazine makes the common diabetes blood test (HbA1c) unreliable. The drug can lower HbA1c levels, potentially hiding new diabetes cases or making existing diabetes seem better controlled than it is. Researchers will use continuous glucose monitors to get a true picture of blood sugar in 75 adults with inflammatory arthritis who take sulfasalazine.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.